GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Endoscopy/Prophylactic Rectal ESD Defect Closure and Post-ESD Outcomes
101

Prophylactic Rectal ESD Defect Closure and Post-ESD Outcomes

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated January 1, 2025

The study explored the impact of prophylactic closure of rectal ESD (endoscopic submucosal dissection) defects on post-ESD outcomes, focusing on delayed adverse events (DAEs) and post-procedure hospitalization. Here are the key findings:

Study Details:

  • Objective: To determine whether closing rectal ESD defects prophylactically improves short-term clinical outcomes, particularly reducing delayed bleeding, perforation, and hospitalization.
  • Population: 385 patients who underwent rectal ESD between 2016 and 2023 across 12 centers in North America and Europe. Patients with intraprocedural perforation were excluded.
  • Intervention: Defect closure was achieved in 166 patients (43%) using techniques like endoscopic suturing, clips, or other closure devices.
  • Outcome Measures: Delayed adverse events (DAEs) — defined as bleeding or perforation within two weeks — and post-procedure hospitalization rates were analyzed.

Key Findings:

  1. Delayed Adverse Events (DAEs):
  • Overall, DAEs occurred in 5.5% of patients.
  • Risk factors for DAEs included chronic anticoagulant use, NICE 3 lesions (high-risk features), and incomplete resections.
  • Prophylactic defect closure did not significantly reduce the overall rate of DAEs compared to leaving defects open.
  • Delayed perforations were observed exclusively in the open-defect group, while no perforations occurred in patients with closed defects.
  1. Hospitalization and Recovery:
  • Patients with defect closure had significantly lower rates of overnight hospital admission or observation following ESD.
  • This suggests that defect closure may improve post-procedure recovery and reduce healthcare resource utilization.
  1. High-Risk Subgroups:
  • In patients with higher risk factors (e.g., anticoagulant use or challenging lesions), defect closure showed a numerical reduction in DAEs, though the difference was not statistically significant.

Clinical Implications:

  • Routine Closure: The study indicates that prophylactic closure may not be necessary for all rectal ESD cases.
  • Selective Closure: Closure is recommended for high-risk patients (e.g., those on anticoagulants or with high-risk lesions) to reduce complications like delayed perforation and hospitalization.

Conclusion:

Prophylactic closure of rectal ESD defects has nuanced benefits. While it may not universally reduce delayed adverse events, it prevents delayed perforation and improves post-procedure recovery, particularly in high-risk patients. The findings suggest a tailored approach, focusing on selective closure for patients with elevated risk profiles to optimize outcomes and resource utilization.

Related Q&A

102

Efficacy of PEG–Ascorbic Acid Plus Linaclotide vs Senna for Bowel Preparation (APPLE Trial)

The APPLE trial (Efficacy of PEG–Ascorbic Acid Plus Linaclotide vs Senna for Bowel Preparation) was a multicenter, endoscopist-blinded, randomized controlled trial conducted across five centers in Japan. The...

103

Spray vs Forced Coagulation in ESD for Early Gastric Neoplasms

The comparison between Spray Coagulation Mode (SCM) and Forced Coagulation Mode (FCM) in Endoscopic Submucosal Dissection (ESD) for early gastric neoplasms has been thoroughly investigated in a multicenter...

104

Impact of the S–O Clip on Endoscopic Submucosal Dissection Outcomes: A Meta-Analysis

The meta-analysis on the impact of the S–O clip on Endoscopic Submucosal Dissection (ESD) outcomes provides compelling evidence supporting the clinical benefits of this traction device. Below is...

105

Comparative Efficacy and Safety of Endoscopic Modalities for Colorectal Cancer Screening in IBD

The comparative efficacy and safety of endoscopic modalities for colorectal cancer (CRC) screening in patients with inflammatory bowel disease (IBD) have been thoroughly investigated in the modern high-definition...

106

Systematic endoscopic characterization of synchronous esophageal, gastric, and colorectal involvement in multisystem Langerhans cell histiocytosis

Systematic endoscopic characterization of synchronous esophageal, gastric, and colorectal involvement in multisystem Langerhans cell histiocytosis (LCH) provides critical insights into the rare and under-recognized gastrointestinal (GI) manifestations of...

107

Endoscopic characterization of synchronous esophageal, gastric, and colorectal involvement in multisystem Langerhans cell histiocytosis

The endoscopic characterization of synchronous esophageal, gastric, and colorectal involvement in multisystem Langerhans cell histiocytosis (LCH) involves identifying specific patterns and features across the gastrointestinal (GI) tract. This...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer